Outcomes in patients with atypical hemolytic uremic syndrome treated with eculizumab in a long-term observational study

Outcomes in patients with atypical hemolytic uremic syndrome treated with eculizumab in a long-term observational study

Abstract Background There are limited long-term outcome data in eculizumab-treated patients with atypical hemolytic uremic syndrome (aHUS). We report final results from the largest prospective, observational, multicenter study of patients with aHUS treated with eculizumab. Methods Patients with aHUS...

Full description

Bibliographic Details
Main Authors: Jan Menne, Yahsou Delmas, Fadi Fakhouri, Christoph Licht, Åsa Lommelé, Enrico E. Minetti, François Provôt, Eric Rondeau, Neil S. Sheerin, Jimmy Wang, Laurent E. Weekers, Larry A. Greenbaum
Format: Article
Language:English
Published: BMC 2019-04-01
Series:BMC Nephrology
Subjects:
Atypical hemolytic uremic syndrome
Alternate complement pathway
Eculizumab
Thrombotic microangiopathy
Online Access:http://link.springer.com/article/10.1186/s12882-019-1314-1

Internet

http://link.springer.com/article/10.1186/s12882-019-1314-1

Similar Items